Legal Representation
Attorney
Barbara E. Johnson, Esq.
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 15, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 15, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 15, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 17, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Sep 17, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jun 18, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 18, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 18, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 5, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| May 5, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Feb 5, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Feb 5, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 5, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Dec 19, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 19, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 19, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 20, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 20, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 20, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 5, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 20, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 16, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Herbal drinks containing the extracts or constituents, or both, of twelve different deciduous fruit tree leaves in combination (e.g., for broad spectrum medicinal use to enhancing healing, namely, for reducing inflammation and conditions related to inflammation and to promote longevity) for medical purposes; liquid herbal supplements containing the extracts or constituents, or both, of twelve different deciduous fruit tree leaves in combination (e.g., for broad spectrum medicinal use to enhance healing, namely, for reducing inflammation and conditions related to inflammation and to promote longevity) for medical purposes.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"LEAVES"